Ridostine
Alternative Names: RidostinLatest Information Update: 22 Mar 1995
At a glance
- Originator Vector
- Class Antivirals; Nucleic acids
- Mechanism of Action Interferon stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Marketed Viral infections
Most Recent Events
- 22 Mar 1995 Launched for Viral infections in Russia (Unknown route)
- 23 Nov 1994 Phase-II clinical trials for Viral infections in Russia (Unknown route)